Evidence map›Paper›PMID 39694102›Full record

Trial reportPreventive medicine2025

Association of individual and neighborhood socioeconomic status with outcomes of a smoking cessation intervention provided in the lung cancer screening setting.

Jaqueline C Avila, Efren J Flores, Yan-Jhu Su, Jennifer S Haas, Elyse R Park, Nancy A Rigotti

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Preventive medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03611881 (Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03611881 phase4completednot on this map

Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening

TypeinterventionalSponsorMassachusetts General HospitalRan2019 to 2024Enrolled642ConditionsSmoking, TobaccoArmsCounseling, Nicotine patch, Community Resource
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jaqueline C AvilaUniversity of Massachusetts Boston, Manning College of Nursing and Health Sciences, Department of Gerontology, Boston, MA, USA; Tobacco Research and Treatment Center, Department of Medicine, and Mongan Institute, Massachusetts General Hospital, Boston, MA, USA. Electronic address: Jaqueline.avila@umb.edu.
Efren J FloresDepartment of Radiology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Yan-Jhu SuUniversity of Massachusetts Boston, Manning College of Nursing and Health Sciences, Department of Gerontology, Boston, MA, USA.
Jennifer S HaasHarvard Medical School, Boston, MA, USA; Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Elyse R ParkHarvard Medical School, Boston, MA, USA; Tobacco Research and Treatment Center, Department of Medicine, and Mongan Institute, Massachusetts General Hospital, Boston, MA, USA; Department of Psychiatry (Psychology), Massachusetts General Hospital, Boston, MA, USA.
Nancy A RigottiHarvard Medical School, Boston, MA, USA; Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Tobacco Research and Treatment Center, Department of Medicine, and Mongan Institute, Massachusetts General Hospital, Boston, MA, USA.

Funding

U Mass Boston / DFHCC U54 Partnership (1 of 2)U54CA156732 · NCI · DANA-FARBER CANCER INST · PI Shoba Ramanadhan · 2010 to 2026
$25.6M
UMass Boston-DF/HCC U54 Partnership (2 of 2)U54CA156734 · NCI · UNIVERSITY OF MASSACHUSETTS BOSTON · PI Jan Mutchler · 2010 to 2026
$24.9M
Research Diversity Supplement Assessing the Integration of Tobacco Cessation Treatment into Lung Cancer ScreeningR01CA218123 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HAAS, JENNIFER S, PARK, ELYSE R. · 2018 to 2022
$4.4M
NCI NIH HHS R01 CA218123NCI NIH HHS U54 CA156732NCI NIH HHS U54 CA156734
6 · The paper itself

Abstract

backgroundLung cancer screening (LCS) offers a teachable moment for smoking cessation. This study assesses whether individual- or neighborhood-level SES is associated with tobacco abstinence and completion of a smoking cessation intervention in the LCS context.

methodsSecondary analysis of a clinical trial (NCT03611881) that tested the effectiveness of smoking cessation treatment for smokers scheduled for LCS (N = 615) in eastern Massachusetts, USA from 2019 to 2024. Outcomes were self-reported 7-day smoking abstinence and study follow-up completion at 6-months. Independent variables were individual SES (high school or less [low SES] vs. post-high school education [high SES]); neighborhood SES (Area Deprivation Index [ADI], range: 0-100, categorized as: highest 15 % [low SES] vs. remaining 85 % scores [high SES]), and a combination of both measures. Logistic regression models tested the association between outcomes and SES measures, adjusted for covariates.

results32 % of participants had low individual SES. The mean sample ADI was 19.9 (SD: 12.8). Smoking cessation was higher among those with high vs. low neighborhood SES (15.7 % vs. 7.4 %, p-value = 0.03). Study completion was marginally higher among those with high vs. low individual SES (84.5 % vs. 78.1 %, p = 0.05). In multivariable models, these associations were not significant, but individuals with high individual and low neighborhood SES were more likely to complete the study than those with both low individual and low neighborhood SES, (OR: 6.04, 95 %CI: 1.47-24.7).

conclusionIndividual and neighborhood SES were not independently associated with the study outcomes in the multivariable analysis, but combinations of individual and neighborhood SES differentially affected treatment completion.

Indexed as

Early Detection of CancerLung NeoplasmsNeighborhood CharacteristicsResidence CharacteristicsSmoking CessationSocial ClassAgedFemaleHumansMaleMassachusettsMiddle AgedLung cancer screeningOlder adultsSmoking cessationSocioeconomic status

Identifiers

PMID39694102
PMCPMC11776097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.